# Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols

> **NCT06429982** · PHASE1 · RECRUITING · sponsor: **Children's National Research Institute** · enrollment: 50 (estimated)

## Conditions studied

- Rhabdomyolysis

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06429982
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06429982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06429982, "Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06429982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*